- ►annals.org PA Bunn, SJ Hoffman, D Norris, LE Golitz, JL … - Annals of internal medicine, 1994 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To review recent studies of systemic therapy for mycosis ... Cited by 162 - Related articles - BL Direct - All 3 versions
- ►ascopubs.org [PDF] TM Kuzel, HH Roenigk Jr, E Samuelson, JJ … - Journal of Clinical Oncology, 1995 - jco.ascopubs.org Purpose: To investigate the efficacy of combined topi- cal tFe•apy and
systemic interferon alfa-2a in patients with mycosis fungoides (MF) and the
S6zary syndrome (SS). Patients and Methods: Between December 1987 and April ... Cited by 103 - Related articles - BL Direct - All 6 versions
FJ Kaye, PA Bunn, SM Steinberg, JL Stocker, … - New England Journal of Medicine, 1989 - content.nejm.org Mycosis fungoides is a T-cell lymphoma that arises in the skin and progresses at
highly variable rates. Nonradomized studies have suggested that early aggressive
therapy may improve the prognosis in this usually fatal disease. We studied ... Cited by 247 - Related articles - All 6 versions
HH Roenigk, TM Kuzel, AP Skoutelis, E … - Journal of Investigative Dermatology, 1990 - nature.com Eighty-two patients with either mycosis fungoides (MF) or parapsoriasis en
plaques were treated with psoralens ultraviolet A light (PUVA). Clinical and
histologic parameters were followed for a period from 6 months to 10 years. ... Cited by 81 - Related articles - All 2 versions
P Heald, A Rook, M Perez, B Wintroub, R … - Journal of the American Academy of Dermatology, 1992 - Elsevier Background: This original cohort of patients with erythrodermic cutaneous T-cell
lymphoma (CTCL) was reported to have clinical improvement with photopheresis
during the 12 months of the original study. No long-term follow-up data ... Cited by 162 - Related articles - All 5 versions
ST Rosen, FM Foss - Hematology/oncology clinics of North America, 1995 - ncbi.nlm.nih.gov Although conventional cytotoxic chemotherapy agents used alone or in combination
have demonstrated activity in MF/SS, there are no studies that clearly
demonstrate improvement in survival of treated patients. Newer compounds ... Cited by 56 - Related articles - BL Direct - All 2 versions
H Honigsmann, A Tanew, PR Bergstresser - Dermatological Phototherapy and Photodiagnostic …, 2001 - books.google.com 6 Photo (chemo) therapy for Cutaneous T-Cell Lymphoma Herbert Honigsmann, Adrian
Tanew, Paul R. Bergstresser Contents UVB Phototherapy 123 Practical Aspects of
UVB Phototherapy 124 Photochemotherapy (PUVA) 125 Response Rates and ... Cited by 68 - Related articles - All 4 versions
GW Jones, RT Hoppe, E Glatstein - Hematology/oncology clinics of North America, 1995 - cat.inist.fr Total skin electron(TSE) radiation methods are complex and technically
demanding. Despite a potential problem of heterogeneity of dose within the
target volume, they have proven effective in managing most patients with ... Cited by 72 - Related articles - BL Direct - All 2 versions
M Duvic, NA Lemak, JR Redman, PJ Eifel, SL … - Journal of the American Academy of Dermatology, 1996 - Elsevier Results: Twenty-eight patients were treated. The overall response rate (complete
and partial remissions) was 82%. Although the median duration of remission was 5
months in patients with stage III to IV disease, two patients remain in ... Cited by 55 - Related articles - BL Direct - All 7 versions
HS Zackheim, M Kashani-Sabet, ST Hwang - Journal of the American Academy of Dermatology, 1996 - cat.inist.fr Background: Most patients with erythrodermic cutaneous T-cell lymphoma(CTCL)
have intense, generalized, refractory pruritus. In some large series the median
survival was approximately 3 years. Objective: Our purpose was to review ... Cited by 55 - Related articles - BL Direct - All 4 versions
